STOCK TITAN

Immunoprecise SEC Filings

IPA NASDAQ

Welcome to our dedicated page for Immunoprecise SEC filings (Ticker: IPA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reading a biotech filing can feel like decoding a lab notebook. ImmunoPrecise Antibodies’ 10-K is packed with R&D spend, patent valuations, and collaboration milestones that span hundreds of pages—and critical insider moves surface in Form 4 minutes before markets react. If you have ever searched “ImmunoPrecise insider trading Form 4 transactions” or wondered how much cash runway the company has left, you know the challenge.

Stock Titan turns that complexity into clarity. Our AI-powered summaries distill every ImmunoPrecise quarterly earnings report 10-Q filing, highlight liquidity trends, and flag key risk factors in plain language. Real-time alerts push ImmunoPrecise Form 4 insider transactions—executive stock purchases, option exercises, and sales—straight to your dashboard. Need deeper context? Click once to see the full document with side-by-side AI notes, perfectly suited for “understanding ImmunoPrecise SEC documents with AI.”

All filing types arrive seconds after EDGAR posts: 8-K material events explained, definitive proxy statement executive compensation tables, and the annual report 10-K simplified for quick reading. Investors use our platform to:

  • Track ImmunoPrecise executive stock transactions Form 4 before material updates
  • Compare segment revenue trends with our ImmunoPrecise earnings report filing analysis
  • Monitor patent additions or collaboration deals via ImmunoPrecise 8-K material events explained
  • Review governance details inside the ImmunoPrecise proxy statement executive compensation section

Whether you type “ImmunoPrecise SEC filings explained simply” into a search engine or prefer ticker-level watchlists, Stock Titan provides comprehensive coverage, AI clarity, and the speed professionals require.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.64%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.6%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.6%
Tags
annual report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.92%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.78%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.43%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.58%
Tags
current report

FAQ

What is the current stock price of Immunoprecise (IPA)?

The current stock price of Immunoprecise (IPA) is $2.49 as of August 28, 2025.

What is the market cap of Immunoprecise (IPA)?

The market cap of Immunoprecise (IPA) is approximately 126.9M.
Immunoprecise

NASDAQ:IPA

IPA Rankings

IPA Stock Data

126.92M
41.92M
9.07%
8.67%
1.57%
Biotechnology
Healthcare
Link
United States
Austin